Total Payments
$632.42
2024 Payments
$349.31
Companies
5
Transactions
27
Payment Breakdown by Category
Food & Beverage$632.42 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $632.42 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $559.74 | 22 | $0 (2024) |
| ViiV Healthcare Company | $29.94 | 2 | $0 (2022) |
| SCILEX PHARMACEUTICALS INC. | $14.77 | 1 | $0 (2021) |
| ABBVIE INC. | $14.52 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $13.45 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $349.31 | 11 | GlaxoSmithKline, LLC. ($321.34) |
| 2023 | $212.27 | 11 | GlaxoSmithKline, LLC. ($212.27) |
| 2022 | $43.42 | 3 | ViiV Healthcare Company ($29.94) |
| 2021 | $27.42 | 2 | SCILEX PHARMACEUTICALS INC. ($14.77) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: VACCINE | ||||||
| 08/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: RESPIRATORY | ||||||
| 03/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: RESPIRATORY | ||||||
| 03/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $107.76 | General |
| Category: RESPIRATORY | ||||||
| 01/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: RESPIRATORY | ||||||
| 01/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: VACCINES | ||||||
| 03/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2022 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: HIV | ||||||
| 03/10/2022 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: HIV | ||||||
| 02/24/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: VACCINES | ||||||
About Aida Mecaral-Sese
Aida Mecaral-Sese is a Acute Care healthcare provider based in Piscataway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1396077129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aida Mecaral-Sese has received a total of $632.42 in payments from pharmaceutical and medical device companies, with $349.31 received in 2024. These payments were reported across 27 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($632.42).
Ad
Practice Information
- Specialty Acute Care
- Location Piscataway, NJ
- Active Since 02/04/2010
- Last Updated 02/04/2010
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396077129
Products in Payments
- AREXVY (Drug) $239.48
- TRELEGY ELLIPTA (Drug) $181.83
- BEXSERO (Biological) $124.95
- RUKOBIA (Drug) $15.21
- ZTLido (Drug) $14.77
- APRETUDE (Biological) $14.73
- LINZESS (Drug) $14.52
- SHINGRIX (Biological) $13.48
- GARDASIL (Biological) $13.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.